A phase II clinical trial of carbon-ion radiotherapy using 2 fractions for hepatocellular carcinoma smaller than and equal to 30mm
Not Applicable
- Conditions
- hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000013537
- Lead Sponsor
- SAGA HIMAT foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient recieved any other therapies for hepatocellular carcinoma within 4 weeks from the first day of the carbon-ion radiotherapy. 2) The alimentary tract is included in and adjacent to the planning target volume. 3) Patient with ascites. 4) Patient with hepatic encephalopathy. 5) Patient with sever paraesophageal varix or portal hypertention. 6) Patient with intractable esophageal or gastric varix. 7) Patients with any other active malignancies. 8) Patients with active and intractable infection at the same position where carbon-ion radiotherapy is planned.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 3-year local control rate
- Secondary Outcome Measures
Name Time Method Overall survival Cause-specific survival Normal tissue reaction